PURPOSE: During reperfusion, following myocardial ischemia, uncompensated loss of citric acid cycle (CAC) intermediates may impair CAC flux and energy transduction. Propionate has an anaplerotic effect when converted to the CAC intermediate succinyl-CoA, and may improve contractile recovery during reperfusion. Antioxidant therapy with N-acetylcysteine decreases reperfusion injury. To synergize the antioxidant effects of cysteine with the anaplerotic effects of propionate, we synthesized a novel bi-functional compound, N,S-dipropionyl cysteine ethyl ester (DPNCE) and tested its anaplerotic and anti-oxidative capacity in anesthetized pigs. METHODS: Ischemia was induced by a 70% reduction in left anterior descending coronary artery flow for one hour, followed by 1 h of reperfusion. After 30 min of ischemia and throughout reperfusion animals were treated with saline or intravenous DPNCE (1.5 mg x kg(-1) x min(-1), n = 8/group). Arterial concentrations and myocardial propionate, cysteine, free fatty acids, glucose and lactate uptakes, cardiac mechanical functions, myocardial content of CAC intermediates and oxidative stress were assessed. RESULTS: Ischemia resulted in reduction in myocardial tissue concentration of CAC intermediates. DPNCE treatment elevated arterial propionate and cysteine concentrations and myocardial propionate uptake, and increased myocardial concentrations of citrate, succinate, fumarate, and malate compared to saline treated animals. DPNCE treatment did not affect blood pressure or myocardial contractile function, but increased arterial free fatty acid concentration and myocardial fatty acid uptake. Arterial cysteine concentration was elevated by DPNCE, but there was negligible myocardial cysteine uptake, and no change in markers of oxidative stress. CONCLUSION: DPNCE elevated arterial cysteine and propionate, and increased myocardial concentration of CAC intermediates, but did not affect mechanical function or oxidative stress.
PURPOSE: During reperfusion, following myocardial ischemia, uncompensated loss of citric acid cycle (CAC) intermediates may impair CAC flux and energy transduction. Propionate has an anaplerotic effect when converted to the CAC intermediate succinyl-CoA, and may improve contractile recovery during reperfusion. Antioxidant therapy with N-acetylcysteine decreases reperfusion injury. To synergize the antioxidant effects of cysteine with the anaplerotic effects of propionate, we synthesized a novel bi-functional compound, N,S-dipropionyl cysteine ethyl ester (DPNCE) and tested its anaplerotic and anti-oxidative capacity in anesthetized pigs. METHODS:Ischemia was induced by a 70% reduction in left anterior descending coronary artery flow for one hour, followed by 1 h of reperfusion. After 30 min of ischemia and throughout reperfusion animals were treated with saline or intravenous DPNCE (1.5 mg x kg(-1) x min(-1), n = 8/group). Arterial concentrations and myocardial propionate, cysteine, free fatty acids, glucose and lactate uptakes, cardiac mechanical functions, myocardial content of CAC intermediates and oxidative stress were assessed. RESULTS:Ischemia resulted in reduction in myocardial tissue concentration of CAC intermediates. DPNCE treatment elevated arterial propionate and cysteine concentrations and myocardial propionate uptake, and increased myocardial concentrations of citrate, succinate, fumarate, and malate compared to saline treated animals. DPNCE treatment did not affect blood pressure or myocardial contractile function, but increased arterial free fatty acid concentration and myocardial fatty acid uptake. Arterial cysteine concentration was elevated by DPNCE, but there was negligible myocardial cysteine uptake, and no change in markers of oxidative stress. CONCLUSION:DPNCE elevated arterial cysteine and propionate, and increased myocardial concentration of CAC intermediates, but did not affect mechanical function or oxidative stress.
Authors: Wenjun Z Martini; William C Stanley; Hazel Huang; Christine Des Rosiers; Charles L Hoppel; Henri Brunengraber Journal: Am J Physiol Endocrinol Metab Date: 2002-10-08 Impact factor: 4.310
Authors: Margaret P Chandler; Hazel Huang; Tracy A McElfresh; William C Stanley Journal: Am J Physiol Heart Circ Physiol Date: 2002-05 Impact factor: 4.733
Authors: A E Reszko; T Kasumov; B Comte; B A Pierce; F David; I R Bederman; J Deutsch; C Des Rosiers; H Brunengraber Journal: Anal Biochem Date: 2001-11-01 Impact factor: 3.365
Authors: Kayla M Pound; Natalia Sorokina; Kalpana Ballal; Deborah A Berkich; Mathew Fasano; Kathryn F Lanoue; Heinrich Taegtmeyer; J Michael O'Donnell; E Douglas Lewandowski Journal: Circ Res Date: 2009-02-12 Impact factor: 17.367
Authors: William C Stanley; Krista M Kivilo; Ashish R Panchal; Peter H Hallowell; Catherine Bomont; Takhar Kasumov; Henri Brunengraber Journal: Cardiovasc Drugs Ther Date: 2003-05 Impact factor: 3.727
Authors: Aneta E Reszko; Takhar Kasumov; Bradley A Pierce; France David; Charles L Hoppel; William C Stanley; Christine Des Rosiers; Henri Brunengraber Journal: J Biol Chem Date: 2003-06-24 Impact factor: 5.157
Authors: Takhar Kasumov; Andrea V Cendrowski; France David; Kathryn A Jobbins; Vernon E Anderson; Henri Brunengraber Journal: Arch Biochem Biophys Date: 2007-03-12 Impact factor: 4.013
Authors: Gangarao Davuluri; Allawy Allawy; Samjhana Thapaliya; Julie H Rennison; Dharmvir Singh; Avinash Kumar; Yana Sandlers; David R Van Wagoner; Chris A Flask; Charles Hoppel; Takhar Kasumov; Srinivasan Dasarathy Journal: J Physiol Date: 2016-10-23 Impact factor: 5.182
Authors: Takhar Kasumov; Ling Li; Min Li; Kailash Gulshan; John P Kirwan; Xiuli Liu; Stephen Previs; Belinda Willard; Jonathan D Smith; Arthur McCullough Journal: PLoS One Date: 2015-05-20 Impact factor: 3.240